Re: Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
Re: Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
复制标题
回复:未经局部治疗的 DCIS 患者的癌症结果。
DOI:
10.1093/jnci/djz118
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Buist,DianaSM
中科院分区:
文献类型:
--
作者:
Habel,LaurelA;Buist,DianaSM
We read with interest the recent article by Ryser et al.(1) on cancer outcomes among women diagnosed with ductal carcinoma in situ (DCIS) from 1992 to 2014 and classified as not receiving definitive surgery or radiotherapy in the Surveillance, Epidemiology and End Results (SEER) registry. They followed 1286 women for a median of 5.5 years and reported a surprisingly low 10-year cumulative ipsilateral invasive breast cancer (iIBC) risk of 10.5%(95% confidence interval [CI]= 8.5% to 12.4%).To contrast, the National Surgical Adjuvant Breast and Bowel Project B-17 clinical trial compared iIBC rates in 817 women with DCIS who received lumpectomy (achieving clear surgical margins) alone vs lumpectomy with radiotherapy and reported 10-year cumulative incidence rates of 16.4%(95% CI= 13.7% to 19.1%) and 5.5%(95% CI= 3.4% to 7.6%), respectively (2). Another recent study of DCIS followed up 89 women diagnosed on needle biopsy with no surgical resection for at least 1year and reported that 33% developed iIBC after a median interval of 45 months (3). Thus, the iIBC rate for untreated DCIS in SEER (1) is more than one-third lower than the rate reported for women in the B-17 trial whose tumors had been completely excised (2) and more than two-thirds lower than a recent study of unresected DCIS (3).